Bilal Bin Hafeez

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Subhash C. Chauhan · 9 shared papers, 2017–2025 · strength 1.15
   • Paper Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic … DOI 10.1016/j.tranon.2025.102432↗
   • Paper Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells. DOI 10.3390/cancers16193431↗
   • Paper Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. DOI 10.3390/biomedicines9121814↗
2. Murali Mohan Yallapu · 8 shared papers, 2017–2025 · strength 0.96
   • Paper Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic … DOI 10.1016/j.tranon.2025.102432↗
   • Paper Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. DOI 10.3390/biomedicines9121814↗
   • Paper Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Ef… DOI 10.1021/acsomega.0c00793↗
3. Meena Jaggi · 7 shared papers, 2017–2022 · strength 0.69
   • Paper Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. DOI 10.3390/biomedicines9121814↗
   • Paper Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Ef… DOI 10.1021/acsomega.0c00793↗
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
4. Sonam Kumari · 6 shared papers, 2017–2022 · strength 0.56
   • Paper Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. DOI 10.3390/biomedicines9121814↗
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
5. Sheema Khan · 5 shared papers, 2017–2022 · strength 0.48
   • Paper Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. DOI 10.3390/biomedicines9121814↗
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
6. Mudassier Ahmad · 2 shared papers, 2024–2025 · strength 0.46
   • Paper Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic … DOI 10.1016/j.tranon.2025.102432↗
   • Paper Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells. DOI 10.3390/cancers16193431↗
7. Mohammed Sikander · 4 shared papers, 2017–2022 · strength 0.40
   • Paper Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. DOI 10.3390/biomedicines9121814↗
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
8. Saini Setua · 4 shared papers, 2019–2020 · strength 0.38
   • Paper Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Ef… DOI 10.1021/acsomega.0c00793↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. DOI 10.1186/s13046-018-1009-7↗
9. Vivek Kumar Kashyap · 3 shared papers, 2019–2022 · strength 0.29
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. DOI 10.1186/s13046-018-1009-7↗
10. Anupam Dhasmana · 1 shared paper, 2025 · strength 0.27
    • Paper Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic … DOI 10.1016/j.tranon.2025.102432↗
11. Stephen W. Behrman · 3 shared papers, 2017–2022 · strength 0.26
    • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
    • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
    • Paper MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression. DOI 10.1038/onc.2016.218↗
12. Advait B. Shetty · 2 shared papers, 2019–2020 · strength 0.21
    • Paper Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Ef… DOI 10.1021/acsomega.0c00793↗
    • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
13. Aun Ali Bangash · 1 shared paper, 2024 · strength 0.20
    • Paper Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells. DOI 10.3390/cancers16193431↗
14. Neeraj Chauhan · 2 shared papers, 2019 · strength 0.17
    • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
    • Paper Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. DOI 10.1186/s13046-018-1009-7↗
15. Andrew E. Massey · 2 shared papers, 2019 · strength 0.17
    • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
    • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
16. Mehdi Chaib · 1 shared paper, 2022 · strength 0.13
    • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
17. Wěi Li · 1 shared paper, 2019 · strength 0.08
    • Paper Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. DOI 10.1186/s13046-018-1009-7↗
18. Zachary E. Stiles · 1 shared paper, 2019 · strength 0.08
    • Paper Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. DOI 10.1016/j.biomaterials.2019.04.005↗
19. Ajit Kumar Verma · 1 shared paper, 2012 · strength 0.04
    • Paper Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via tar… DOI 10.1002/ijc.27478↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.